
QSIAW — Quantum-Si incorporated
NASDAQ · Healthcare · Medical Devices
Quantum-Si incorporated (QSIAW) is a medical devices company listed on NASDAQ. It is led by Jeffrey Alan Hawkins, based in 29 Business Park Drive, Branford, CT, United States, 06405, with about 149 employees. Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an available pro mode; Library preparation kits to prepare protein sample for sequencing; Barcoding Kits to optimize the workflow and performance of technology; and Sequencing Kits contains the reagents and consumables used to perform NGPS on the Platinum or Platinum Pro instrument. It also provides Platinum Analysis Software, a cloud-based solution that automates data analysis workflows and provides a user-friendly interface and visualization of the sequencing results. Its products are used in antibody characterization, biomarker identification, protein identification, protein variants, protein barcoding, and post translational modification analysis applications. Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut.
Latest reported QSIAW revenue for 2025-09-30 was $552.0K. Net income was -$35.7M. Revenue was down 6.6% from 2025-06-30 to 2025-09-30. QSIAW currently screens at market cap $1.44B.
Use this QSIAW page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the QSIAW quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the QSIAW SEC filings page. Lician reads the product cache first so this HTML stays unique to Quantum-Si incorporated even when a live quote feed is slow.
About Quantum-Si incorporated
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an available pro mode; Library preparation kits to prepare protein sample for sequencing; Barcoding Kits to optimize the workflow and performance of technology; and Sequencing Kits contains the reagents and consumables used to perform NGPS on the Platinum or Platinum Pro instrument. It also provides Platinum Analysis Software, a cloud-based solution that automates data analysis workflows and provides a user-friendly interface and visualization of the sequencing results. Its products are used in antibody characterization, biomarker identification, protein identification, protein variants, protein barcoding, and post translational modification analysis applications. Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut.
QSIAW Key Statistics
Market Cap
$1.44B
EPS
-$0.71
Revenue
$3.06M
Net Income
-$101.01M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+182.6%
Profit Margin
-3303.0%
Employees
149
QSIAW Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $3.06M | $1.08M | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$101.01M | -$95.96M | -$132.44M | -$94.99M |
| EPS (Diluted) | -$0.71 | -$0.68 | -$0.95 | -$1.19 |
Total Assets
$247.87M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$49.24M
Operating Cash Flow
-$87.80M
Free Cash Flow
$0.00
Quantum-Si incorporated Company Information
- President, CEO & Director
- Jeffrey Alan Hawkins
- Headquarters
- 29 Business Park Drive, Branford, CT, United States, 06405
- Website
- www.quantum-si.com
- Phone
- 866 688 7374
- IPO / Founded
- 2021-06-11
- Sector
- Healthcare
- Industry
- Medical Devices